Access
To read this story in full you will need to login or make a payment (see right).
News and Views
Nature 441, 582-583 (1 June 2006) | doi:10.1038/441582a; Published online 31 May 2006
Open Innovation Challenges
-
Methods of Modeling Adaptation in Populations
The analysis of adaptation with a population is a frequently encountered computational modeling scen...
-
Optimizing Sub-cellular Localization Tags
The Seeker is looking for methods to optimize sub-cellular localization tags for protein expression....
nature jobs
One Postdoctoral Position at Centre for Research in Agricultural Genomics
- The Centre for Research Agricultural Genomics Consorcio CSIC-IRTA-UAB
- Barcelona Spain
Laboratory Technician (Pharmaceutics)
- Alliance Institute of Advanced Pharmacy and Health Sciences
- Hyderabad 500038 India
Down's syndrome: Critical genes in a critical region
Charles J. Epstein1
Abstract
The NFAT transcription factors activate the expression of many genes involved in the immune response and the development of a variety of tissues. They have now been implicated in Down's syndrome.
Down's syndrome is most commonly caused by the presence of an extra copy of the major portion of human chromosome 21. But how does the presence of an extra set of the roughly 200–300 genes on the chromosome give rise to the many abnormalities that characterize the condition?
- Charles J. Epstein is in the Department of Pediatrics and the Center for Human Genetics, University of California, San Francisco, Rock Hall 584B, 1550 4th Street, San Francisco, California 94143-2911, USA.
Email: charles.epstein@ucsf.edu
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Group founding and breeding structure in the subsocial spider Stegodyphus lineatus (Eresidae)Heredity Original Article
A new member of the IL-1 receptor family highly expressed in hippocampus and involved in X-linked mental retardationNature Genetics Article (01 Sep 1999)
NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21Nature Article (01 Jun 2006)
Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1Nature Letters to Editor (25 Jun 2009)

